logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Enalapril Maleate CAS 76095-16-4 with Molecular Formula

Enalapril Maleate CAS 76095-16-4 with Molecular Formula

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 76095-16-4

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 76095-16-4 Enalapril Maleate

,

Enalapril Maleate

CAS NO::
76095-16-4
Appearance::
White To Off-white Crystalline Power
Molecular Formula::
C24H32N2O9
Molecular Weight::
492.51900
EINECS NO::
278-375-7
MDL NO::
MFCD00133304
CAS NO::
76095-16-4
Appearance::
White To Off-white Crystalline Power
Molecular Formula::
C24H32N2O9
Molecular Weight::
492.51900
EINECS NO::
278-375-7
MDL NO::
MFCD00133304
Enalapril Maleate CAS 76095-16-4 with Molecular Formula

Product Description:

Product Name: Enalapril maleate CAS NO: 76095-16-4

 

 

Synonyms:

Enalapril maleate salt;

((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline compound with maleic acid (1:1);

 

 

Chemical & Physical Properties:

Appearance: White to off-white crystalline power

Assay :≥99.00%

Boiling Point: 0℃

Melting Point: 143-144.5℃

Storage Condition: -20℃ Freezer

Water Solubility: Soluble in water, methanol, and ethanol.

 

 

Safety Information:

Safety Statements: S22; S24/25; S36/37; S26

HS Code: 2933990090

Risk Statements: R36/37/38

Hazard Code: Xi

WGK Germany: 2

RTECS: TW3666000

 

 

An antihypertensive. An angiotensin-converting enzyme (ACE) inhibitor. Enalapril maleate is the second angiotensin converting enzyme inhibitor to reach the marketplace. Like captopril, the first entry in this area, enalapril is useful in the treatment of hypertension and congestive heart failure. It has a longer effective half-life than captopril, allowing once or twice-daily dosing, and appears to have a somewhat lower incidence of side effects.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.